A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Clinical trial NCT02125318 · COMPLETED

Trial details

NCT number: NCT02125318
Sponsor: Galena Biopharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombocytosis Myeloproliferative Neoplasms

Start date: 2014-05-01
Primary completion: 2016-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.